A Multicenter Retrospective Study of Avelumab First-Line Maintenance and Subsequent Therapies for Locally Advanced and Metastatic Urothelial Carcinoma: Subgroup Analysis of First-Line Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, and Gemcitabine Plus Cisplatin in the Japan AVElumab MAintenance and Continuous Treatment Study (JAVEMACS)

Avelumab maintenance therapy is approved in Japan for patients with aUC without progression after PBC. This report presents subgroup analysis data from the JAVEMACS chart review of avelumab maintenance in patients who received 1L ddMVAC and GC. This retrospective study reviewed medical charts of pat...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Masaomi Ikeda, Kiyohide Fujimoto, Noriyoshi Miura, Rikiya Taoka, Kiyoaki Nishihara, Daiki Ikarashi, Sei Naito, Fumitaka Shimizu, Atsuko Fujihara, Michihiro Shono, Tohru Nakagawa, Eiji Kikuchi
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	MDPI AG 2025-11-01
Seri Bilgileri:	Current Oncology
Konular:	treatment patterns ddMVAC GC avelumab enfortumab vedotin urothelial carcinoma
Online Erişim:	https://www.mdpi.com/1718-7729/32/11/618
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!